FTIR- based serum structure analysis in molecular diagnostics of essential thrombocythemia disease

J Photochem Photobiol B. 2023 Aug:245:112734. doi: 10.1016/j.jphotobiol.2023.112734. Epub 2023 Jun 2.

Abstract

Essential thrombocythemia (ET) reflects the transformation of a multipotent hematopoietic stem cell, but its molecular pathogenesis remains obscure. Nevertheless, tyrosine kinase, especially Janus kinase 2 (JAK2), has been implicated in myeloproliferative disorders other than chronic myeloid leukaemia. FTIR analysis was performed on the blood serum of 86 patients and 45 healthy volunteers as control with FTIR spectra-based machine learning methods and chemometrics. Thus, the study aimed to determine biomolecular changes and separation of ET and healthy control groups illustration by applying chemometrics and ML techniques to spectral data. The FTIR-based results showed that in ET disease with JAK2 mutation, there are alterations in functional groups associated with lipids, proteins and nucleic acids significantly. Moreover, in ET patients the lower amount of proteins with simultaneously higher amount of lipids was noted in comparison with the control one. Furthermore, the SVM-DA model showed 100% accuracy in calibration sets in both spectral regions and 100.0% and 96.43% accuracy in prediction sets for the 800-1800 cm-1 and 2700-3000 cm-1 spectral regions, respectively. While changes in the dynamic spectra showed that CH2 bending, amide II and CO vibrations could be used as a spectroscopy marker of ET. Finally, it was found a positive correlation between FTIR peaks and first bone marrow fibrosis degree, as well as the absence of JAK2 V617F mutation. The findings of this study contribute to a better understanding of the molecular pathogenesis of ET and identifying biomolecular changes and may have implications for early diagnosis and treatment of this disease.

Keywords: Essential thrombocythemia (ET); Fourier-transform infrared spectroscopy (FT-IR); Multivariate analysis; Principal component analysis (PCA); Receiver operating characteristic (ROC); Support vector machine discriminant analysis (SVM-DA).

MeSH terms

  • Humans
  • Pathology, Molecular
  • Polycythemia Vera* / diagnosis
  • Polycythemia Vera* / genetics
  • Serum
  • Spectroscopy, Fourier Transform Infrared
  • Thrombocythemia, Essential* / diagnosis
  • Thrombocythemia, Essential* / genetics
  • Thrombocythemia, Essential* / pathology